Glossary

Compounded Semaglutide

A pharmacy-compounded form of semaglutide, the active ingredient in Ozempic and Wegovy, prescribed through telehealth and fulfilled via licensed compounding pharmacies.

Compounded semaglutide is produced by licensed 503A or 503B pharmacies when branded semaglutide products are on the FDA drug shortage list or when a prescriber determines compounding is medically necessary for a patient. It contains the same active ingredient as Ozempic and Wegovy but is not FDA-approved as a finished drug product. Pricing is typically significantly below branded alternatives, which drives demand in cash-pay telehealth programs.

For clinic operators, compounded semaglutide is often the primary product in a GLP-1 weight loss program. Margins are meaningful, and patient acquisition is straightforward given broad awareness of semaglutide by name. The operational challenge is managing prescribing compliance, pharmacy fulfillment, and ongoing clinical oversight at scale - which is exactly the workflow Karpa's platform is built to support.

The regulatory landscape for compounded semaglutide changes. The FDA periodically updates shortage designations, which affect whether compounding is permitted. Operators should monitor FDA communications and work with their pharmacy partners and legal counsel to stay current.

Related Solution

Launch your Compounded Semaglutide program with Karpa

See How It Works

Related Terms

503A Compounding Pharmacy 503B Outsourcing Facility GLP-1 Weight Loss Program

Frequently Asked Questions

Is compounded semaglutide legal to prescribe? expand_more
It is legal when the branded product is on the FDA drug shortage list or when compounding is medically appropriate for a specific patient. Operators should verify current shortage status and ensure their prescribing providers document medical necessity appropriately.
How is compounded semaglutide priced for patients? expand_more
Compounded semaglutide typically costs significantly less than branded Ozempic or Wegovy. Most operators price monthly programs between $200 and $400, covering medication, shipping, and clinical oversight. Karpa's platform supports flexible pricing configurations.
What clinical oversight is required for a semaglutide program? expand_more
Patients require an initial clinical intake, provider evaluation, a valid prescription, and ongoing follow-up. Most programs include monthly or quarterly check-ins. Karpa's platform automates intake, routes cases to licensed providers, and manages follow-up messaging.

Ready to launch your clinic?

Karpa provides everything you need to go live in 2 weeks or less.

Book a Free Demo